Acclarent

About:

Acclarent is a medical device company that develops new technologies to treat patients suffering from ENT disorders.

Website: http://www.acclarent.com

Twitter/X: Acclarent_ENT

Top Investors: New Enterprise Associates, Meritech Capital Partners, ExploraMed, Versant Ventures, Johnson & Johnson Development Corporation

Description:

Acclarent, Inc. is a medical device company. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools—Balloon Sinuplasty® devices. Through the Balloon SinuplastyTM technology and the company's RelievaTM registered product portfolio, we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005, and the products were commercially launched in the US that same year.

Total Funding Amount:

$86M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2004-06-01

Contact Email:

acclarent(AT)acclarent.com

Founders:

John Chang, Josh Makower

Number of Employees:

251-500

Last Funding Date:

2009-01-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai